However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

The Hostages and Missing Families Forum has celebrated the release of Ofer Kalderon, Yarden Bibas and Keith Siegel, after ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...

Patient flow forecasting is a fundamental tool in healthcare and pharmaceutical industries, enabling stakeholders to predict and plan for the treatment requirements of patients accurately.

Ben Krasinski; Director, Investor Relations; Premier Inc. Michael Alkire; President, Chief Executive Officer, Director; Premier Inc. Glenn Coleman; Chief Financial O ...

James Bjornholt; Chief Financial Officer, Senior Vice President; Microchip Technology Inc Richard Simoncic; Senior Vice President - Analog Power and Interface Business Units; Microchip Technology Inc ...

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today reports its IFRS unaudited estimated financial results for the fourth quarter 2024 and full year ended December 31, 2024. The Group’s ...

RA takes a toll on mental health, with some estimates that up to 22% of RA patients have depression. In one study, more than 50% of RA patients who reached remission sustained it for at least two ...

Proteinuria identifies patients with established CKD and faster disease progression and should be routinely tested during LVAD candidacy assessment ... use because they do not account for pulmonary ...

Haemonetics Corporation (market cap: $3.23B) reported its third-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $1.19, slightly ...